1-6 of 6
Charles Herbaux
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

Vincent Camus, Roch Houot, Gabriel Brisou, Benoit Tessoulin, Sébastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Franck Morschhauser, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérome Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5371–5381.
https://doi.org/10.1182/bloodadvances.2024013726
Published: 2024
Includes: Supplemental data
Journal Articles

PI3Kδ activation, IL6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Alberto J Arribas, Sara Napoli, Eugenio Gaudio, Charles Herbaux, Eleonora Cannas, Chiara Tarantelli, Roberta Bordone Pittau, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S Davids, Francesco Bertoni
Journal: Blood Advances
Blood Adv bloodadvances.2023012291.
https://doi.org/10.1182/bloodadvances.2023012291
Published: 2024
Includes: Supplemental data
Journal Articles

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Clinical Trials & Observations
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Rene-Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6589–6598.
https://doi.org/10.1182/bloodadvances.2023010624
Published: 2023
Includes: Supplemental data
Journal Articles

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

Clinical Trials & Observations
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon, Jean Marc Schiano, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Caroline Besson, Eric Durot, Christophe Bonnet, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie-Cécile Parrens, Gandhi Damaj
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5733–5742.
https://doi.org/10.1182/bloodadvances.2022008524
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Clinical Trials & Observations
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Béatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Delphine Nollet, Damien Roos-Weil, Sylvie Chevret, Véronique Leblond
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2438–2446.
https://doi.org/10.1182/bloodadvances.2020003895
Published: 2021
Includes: Supplemental data